Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease

Gastroenterology. 2019 Dec;157(6):1448-1456.e1. doi: 10.1053/j.gastro.2019.08.048. Epub 2019 Sep 12.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Child
  • Clinical Trials as Topic*
  • Drug Development*
  • Humans
  • Liver / pathology
  • Non-alcoholic Fatty Liver Disease / diagnosis
  • Non-alcoholic Fatty Liver Disease / drug therapy*
  • Non-alcoholic Fatty Liver Disease / epidemiology
  • Patient Selection
  • Prevalence
  • Severity of Illness Index